The South African Health Products Regulatory Authority (SAHPRA) has published four (4) Expression of Interests (EOIs) since 2023, and these have all been closed. Updates on EOIs: Ref: SAHPRA69092024 - Pharmaceutical Evaluations Management EOI closed on Friday, 26 April 2024. Appointments were made. Ref: SAHPRA20862023 - The EOI...
Pretoria, 16 September 2024 –The South African Health Products Regulatory Authority (SAHPRA) is proud to announce that it has received its first clean audit outcome from the Auditor-General of South Africa (AGSA) for the 2023/2024 financial year, following on a record of consistent unqualified audit...
The South African Health Products Regulatory Authority (SAHPRA) recently hosted the 3rd webinar in our Codeine Care Initiative (CCI) series, focusing on Patient Safety – Codeine’s Place in Pharmaceutical Care. Following our first module, which centred on holistic management for pain, cough, and colds, and the...
Pretoria, 22 July 2024 –The South African Health Products Regulatory Authority (SAHPRA) is disappointed with the unfounded fallacies and misrepresentation in circulation and churned out by some media organisations without verification, in what presents as a misinformation campaign devoid of any intent to rely on...
The South African Health Products Regulatory Authority (SAHPRA) hosted an informative workshop on the upcoming eCTD Specification 3.1 and the launch of the new Application Submission Portal. This was the first of three workshops. Presentations Download Presentation Watch Recording ...
The South African Health Products Regulatory Authority (SAHPRA) recently hosted the launch webinar for our Codeine Care Initiative (CCI) series. This inaugural webinar focused on the holistic management of pain, cough, and colds. What was covered: Insightful information on pain, cold, and cough management. An engaging...
The South African Association of Pharmacists in Industry (SAAPI) held its 2024 conference at the Council for Scientific and Industrial Research (CSIR) International Convention Centre on 5-7 June 2024 under the theme “Engage and empower: Pushing the frontiers of the Pharma Industry”. South African Health Products...
The South African Health Products Regulatory Authority (SAHPRA) hosted an industry workshop to empower and educate you on the FAQs & Common Deficiencies for APIMF [Active Pharmaceutical Ingredient Master File] Submission. The workshop provided information to the Industry Stakeholders and APIMF holders on the SAHPRA’s current...
Pretoria, 05 June 2024 –On 13 April 2024, the South African Health Products Regulatory Authority (SAHPRA) initiated a precautionary recall of two batches of Benylin Paediatric Syrup (batch numbers 329303 and 329304), in response to reported high levels of diethylene glycol in an alert by...
Pretoria, 29 May 2024 –The South African Health Products Regulatory Authority (SAHPRA) has attained its ISO 9001:2015 certification following a rigorous audit by the South African Bureau of Standards (SABS), a milestone that serves as a testament to the implementation of an effective and robust...
